DCA

Title	Average Rating
DCA	97.50%
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.	95.00%
Dichloroacetic acid	90.00%
Metabolic modulation of glioblastoma with dichloroacetate.	90.00%
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds	80.00%
Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy	80.00%
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo	70.00%
Anti-cancer drugs that target metabolism, is dichloroacetate the new paradigm?	70.00%
Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.	60.00%
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.

Languages